UConn Health Researchers Work with Startup on Colon Cancer Vaccine
from University of Connecticut
The University of Connecticut and emerging immunotherapy company CaroGen Corp. have begun a collaboration to develop a vaccine for treatment of patients with colon cancer. CaroGen's proprietary technology platform will be applied to a specific target studied by UConn Health researchers Kepeng Wang, assistant professor of immunology, and Anthony T. Vella, professor and Boehringer Ingelheim Chair in Immunology.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063